609 related articles for article (PubMed ID: 26038872)
1. Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation.
Wozniak LJ; Hickey MJ; Venick RS; Vargas JH; Farmer DG; Busuttil RW; McDiarmid SV; Reed EF
Transplantation; 2015 Jul; 99(7):1416-22. PubMed ID: 26038872
[TBL] [Abstract][Full Text] [Related]
2. C1q-binding DSA and allograft outcomes in pediatric kidney transplant recipients.
Hayde N; Solomon S; Caglar E; Ge J; Qama E; Colovai A
Pediatr Transplant; 2021 Mar; 25(2):e13885. PubMed ID: 33131194
[TBL] [Abstract][Full Text] [Related]
3. Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing.
Süsal C; Wettstein D; Döhler B; Morath C; Ruhenstroth A; Scherer S; Tran TH; Gombos P; Schemmer P; Wagner E; Fehr T; Živčić-Ćosić S; Balen S; Weimer R; Slavcev A; Bösmüller C; Norman DJ; Zeier M; Opelz G;
Transplantation; 2015 Sep; 99(9):1976-80. PubMed ID: 25769065
[TBL] [Abstract][Full Text] [Related]
4. The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes.
Freitas MC; Rebellato LM; Ozawa M; Nguyen A; Sasaki N; Everly M; Briley KP; Haisch CE; Bolin P; Parker K; Kendrick WT; Kendrick SA; Harland RC; Terasaki PI
Transplantation; 2013 May; 95(9):1113-9. PubMed ID: 23514959
[TBL] [Abstract][Full Text] [Related]
5. Prospective Monitoring of Donor-specific Anti-HLA Antibodies After Intestine/Multivisceral Transplantation: Significance of De Novo Antibodies.
Kubal C; Mangus R; Saxena R; Lobashevsky A; Higgins N; Fridell J; Tector AJ
Transplantation; 2015 Aug; 99(8):e49-56. PubMed ID: 25769071
[TBL] [Abstract][Full Text] [Related]
6. Crossmatch-positive liver transplantation in patients receiving thymoglobulin-rituximab induction.
Kubal CA; Mangus RS; Saxena R; Lobashevsky A; Higgins N; Agarwal A; Fridell JA; Tector AJ
Transplantation; 2014 Jan; 97(1):56-63. PubMed ID: 24030603
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and Clinical Impact of Donor-Specific Alloantibody Among Intestinal Transplant Recipients.
Cheng EY; Everly MJ; Kaneku H; Banuelos N; Wozniak LJ; Venick RS; Marcus EA; McDiarmid SV; Busuttil RW; Terasaki PI; Farmer DG
Transplantation; 2017 Apr; 101(4):873-882. PubMed ID: 27490417
[TBL] [Abstract][Full Text] [Related]
8. Long-term Clinical Relevance of De Novo Donor-Specific Antibodies After Pediatric Liver Transplantation.
Grabhorn E; Binder TM; Obrecht D; Brinkert F; Lehnhardt A; Herden U; Peine S; Nashan B; Ganschow R; Briem-Richter A
Transplantation; 2015 Sep; 99(9):1876-81. PubMed ID: 25706279
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
[TBL] [Abstract][Full Text] [Related]
10. Class II Human Leukocyte Antigen Epitope Mismatch Predicts De Novo Donor-Specific Antibody Formation After Liver Transplantation.
Kubal CA; Mangus R; Ekser B; Mihaylov P; Ceballos B; Higgins N; Chalasani N; Ghabril M; Nephew L; Lobashevsky A
Liver Transpl; 2018 Aug; 24(8):1101-1108. PubMed ID: 30142248
[TBL] [Abstract][Full Text] [Related]
11. HLA, Non-HLA Antibodies, and Eplet Mismatches in Pediatric Liver Transplantation: Observations From a Small, Single-Center Cohort.
Ekong UD; Antala S; Bow L; Sese D; Morotti R; Rodriguez-Davalos M; Gan G; Deng Y; Emre SH
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):6-17. PubMed ID: 30777518
[TBL] [Abstract][Full Text] [Related]
12. Donor-specific HLA antibodies: risk factors and outcomes after kidney transplantation.
Kanter Berga J; Pallardo Mateu LM; Beltran Catalan S; Puig Alcaraz N; Sancho Calabuig A; Gavela Martinez E; Avila Bernabeu A; Crespo Albiach J
Transplant Proc; 2011; 43(6):2154-6. PubMed ID: 21839219
[TBL] [Abstract][Full Text] [Related]
13. De novo donor specific antibodies and patient outcomes in renal transplantation.
DeVos JM; Patel SJ; Burns KM; Dilioglou S; Gaber LW; Knight RJ; Gaber AO; Land GA
Clin Transpl; 2011; ():351-8. PubMed ID: 22755430
[TBL] [Abstract][Full Text] [Related]
14. Effect of persistent versus transient donor-specific HLA antibodies on graft outcomes in pediatric cardiac transplantation.
Irving CA; Carter V; Gennery AR; Parry G; Griselli M; Hasan A; Kirk CR
J Heart Lung Transplant; 2015 Oct; 34(10):1310-7. PubMed ID: 26123951
[TBL] [Abstract][Full Text] [Related]
15. The Significance of Screening for HLA Antibodies in the Long-Term Follow-up of Pediatric Liver Transplant Recipients.
Tokodai K; Kawagishi N; Miyagi S; Nakanishi C; Hara Y; Fujio A; Kashiwadate T; Maida K; Goto H; Kamei T; Ohuchi N
Transplant Proc; 2016 May; 48(4):1139-41. PubMed ID: 27320574
[TBL] [Abstract][Full Text] [Related]
16. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.
DeVos JM; Gaber AO; Knight RJ; Land GA; Suki WN; Gaber LW; Patel SJ
Kidney Int; 2012 Sep; 82(5):598-604. PubMed ID: 22622504
[TBL] [Abstract][Full Text] [Related]
17. Post-transplant development of C1q-positive HLA antibodies and kidney graft survival.
Piazza A; Poggi E; Ozzella G; Adorno D
Clin Transpl; 2013; ():367-75. PubMed ID: 25095531
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
Crespo M; Torio A; Mas V; Redondo D; Pérez-Sáez MJ; Mir M; Faura A; Guerra R; Montes-Ares O; Checa MD; Pascual J
Transpl Immunol; 2013 Dec; 29(1-4):28-33. PubMed ID: 23907088
[TBL] [Abstract][Full Text] [Related]
19. Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation.
Malheiro J; Tafulo S; Dias L; Martins S; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
Transpl Int; 2017 Apr; 30(4):347-359. PubMed ID: 27717025
[TBL] [Abstract][Full Text] [Related]
20. High tacrolimus intra-patient variability is associated with graft rejection, and
Del Bello A; Congy-Jolivet N; Danjoux M; Muscari F; Lavayssière L; Esposito L; Hebral AL; Bellière J; Kamar N
World J Gastroenterol; 2018 Apr; 24(16):1795-1802. PubMed ID: 29713132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
